Growing geriatric population and rising prevalence of brain tumour are key driving factors for growth of brain tumor diagnosis and treatment market across the globe.
As per a report published by the WHO in the year 2012, over 14 million people were diagnosed with brain tumour. Also, 8.2 million deaths were caused due to the tumour. Furthermore, it is stated that morbidity rate is anticipated to increase by approximately 70% in next two decades.
Likewise, as per a report published by the Global Health Observatory (GHO) in the year 2015,it is clearly mentioned that the number of caused due to cancer is likely to increase by 44.0% by 2030.
The market for treatment of brain tumour is likely to grow proportionally with rising incidence of brain tumour and increasing death rate over the forecast period. Various government bodies such as International Brain Tumor Alliance, the WHO, and American Brain Tumor Association have come together for research of treatment to cure the disease.
On the basis of therapeutics, the market has been bifurcated into chemotherapy, immunotherapy, radiation therapy, targeted therapy, and surgery. Surgery is anticipated to be leading contributing segment to the brain tumour and diagnosis and treatment market, in terms of revenue. The dominance of the segment is attributed to low awareness level and less diagnostics options. As a result, the disease gets aggravated to grade IV stage. Further, the trend is likely to continue in coming years as well.
Moreover, radiation therapy segment is anticipated to exhibit substantial growth rate in forthcoming years. The therapy uses gamma rays, x-rays, or protons to kill the cancer cell.
Global Brain Tumor Diagnosis and Treatments Market: Snapshot
The demand in the global market for brain tumor diagnosis and treatments is anticipated to increase at a potent CAGR of 8.5% during the forecast period of 2017 to 2025. The prosperity of this market is primarily a reflection of innovations in drug delivery to brain cancer cells, increasing prevalence of brain cancer, rising aging population, and growing incidences of cancer via chemical exposure. On the other hand, exponentially high cost of diagnostic as well as treatment is the most prominent hindrance over this market. The global for brain tumor diagnosis and treatments market was worth US$406.0 mn in 2016, and is estimated to reach a valuation of US$840.7 mn by the end of the forecast period, which is 2025.
CT-Scan Remains High-Demand Diagnosis Segment
Based on product-type, the global brain tumor diagnosis and treatments market has been segmented into primary brain tumor and secondary brain tumor. The primary brain tumor segment, which accounted for 74.7% of the overall demand in 2016, has been sub-segmented into common tumors such as meningioma, astrocytomas, gliomas, and pituitary tumors. Along all sub-segments, meningioma continues to be most prevalent across the world, including Asia Pacific and Europe. It has been observed that in these two regions, CNS and brain tumors are the third most common cancer among young adults and juveniles, causing most of the cancer-related deaths in this age group. The report projects the segment of primary brain tumor to witness an incrementing demand at CAGR of 8.7% during the forecast period from 2017 to 2025.
On the basis of diagnosis type, the global brain tumor diagnosis and treatments market has been bifurcated into CT-Scan, MRI, Molecular Testing, PET-CT Scan, and EEG, with the former accounting for more than 35% share of global market in 2016. It has been noted that CT-Scan remain the most preferred choice of brain cancer diagnosis, owing to their ability to effectively differentiate between bone masses and elaborate soft tissues, besides offering the option to click 3D images in a series at multiple angle. In addition to that, upcoming technological advancements in innovative mobile CT-Scan devices are also expected to aid to the growth of the CT-Scan diagnosis segment during the forecast period. Treatment-wise, surgery category has remained the most preferable primary treatment for brain tumor. It has identified as the first and the only treatment for most type of the brain tumors. That being said, radiation therapy is projected for a strong growth rate during forecast period of 2017 to 2025, a result of growing awareness regarding noninvasive novel treatment due to technological advancements.
Europe Projected for the Best Growth Rate
In 2016, North America accounted for the most prominent share of the demand for brain tumor diagnosis and treatments. The U.S. dominated the brain tumor diagnosis and treatments market in North America, serving about 89.3% share in of North America market in 2016. This dominance is essentially due to the factors such as large number of people diagnosed with brain tumor, extensive research and development activities, technological advancements, and increasing healthcare awareness about the treatment and management of brain tumor are driving market growth. On the other hand, Europe is projected for the best CAGR among all regions during the forecast period, gaining substantial demand from the countries of Germany and The U.K. Rising prevalence of brain tumors disease, escalating percentage of geriatrics among the European population, and government’s initiative regarding growing awareness of advanced technologies are some of the key factors driving the brain tumor diagnosis and treatments market in Europe.
Pfizer, Inc., Toshiba Medical Systems, GE Healthcare, AstraZeneca, Merck & Co., Inc., Siemens Healthineers, Carestream Health, Hitachi Medical Corporation, Philips Healthcare, and Shimadzu Corporation are some of the key companies currently operating in the global brain tumor diagnosis and treatments market.
The global brain tumor diagnosis and treatments market is segmented as follows:
|
by Product Type |
|
|
by Product Analysis |
|
|
by Diagnosis Type |
|
|
by Treatment Type |
|
|
by Geography |
|
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Brain Tumor Diagnosis and Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Product Overview
4.1.2. Key Industry Events
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity
4.3. Porter’s Five Forces Analysis
4.4. Value Chain Analysis
4.5. Market Outlook
5. Global Brain Tumor Diagnosis and Treatments Market Analysis and Forecasts, By Product Type
5.1. Key Findings / Developments
5.2. Introduction & Definition
5.3. Market Value Forecast By Product Type , 2017-2025
5.3.1. Primary Brain Tumor
5.3.1.1. Meningioma
5.3.1.2. Gliomas
5.3.1.3. Astrocytomas
5.3.1.4. Pituitary Tumors
5.3.1.5. Others
5.3.2. Secondary Brain Tumor
5.4. Key Trends
5.5. Market Attractiveness By Product Type
6. Global Brain Tumor Diagnosis and Treatments Market Analysis and Forecasts, By Diagnosis Type
6.1. Key Findings / Developments
6.2. Introduction & Definition
6.3. Market Value Forecast By Diagnosis Type, 2017–2025
6.3.1. CT Scan
6.3.2. MRI
6.3.3. PET-CT Scan
6.3.4. Molecular Testing
6.3.5. EEG
6.3.6. Others
6.4. Key Trends
6.5. Market Attractiveness By Diagnosis Type
7. Global Brain Tumor Diagnosis and Treatments Market Analysis and Forecasts, By Treatment Type
7.1. Key Findings / Developments
7.2. Introduction & Definition
7.3. Market Value Forecast By Treatment Type, 2017–2025
7.3.1. Surgery
7.3.2. Radiation Therapy
7.3.3. Targeted Therapy
7.3.4. Chemotherapy
7.3.5. Immunotherapy
7.4. Key Trends
7.5. Market Attractiveness By Diagnosis Type
8. Global Brain Tumor Diagnosis and Treatments Market Analysis and Forecasts, by Region
8.1. Policies and Regulations
8.2. Market Value Forecast By Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis By Region
9. North America Brain Tumor Diagnosis and Treatments Market Analysis and Forecast
9.1. Market Value Forecast By Country, 2017-2025
9.1.1. U.S.
9.1.2. Canada
9.2. Market Value Forecast By Product Type
9.3. Market Value Forecast By Diagnosis Type
9.4. Market Value Forecast By Treatment Type
9.5. Market Attractiveness Analysis
9.5.1. By Country
9.5.2. By Product Type
9.5.3. By Diagnosis Type
9.5.4. By Treatment Type
10. Europe Brain Tumor Diagnosis and Treatments Analysis and Forecast
10.1. Market Value Forecast By Country, 2017-2025
10.1.1. Germany
10.1.2. Spain
10.1.3. France
10.1.4. U.K.
10.1.5. Italy
10.1.6. Rest of Europe
10.2. Market Value Forecast By Product Type
10.3. Market Value Forecast By Diagnosis Type
10.4. Market Value Forecast By Treatment Type
10.5. Market Attractiveness Analysis
10.5.1. By Country
10.5.2. By Product Type
10.5.3. By Diagnosis Type
10.5.4. By Treatment Type
11. Asia Pacific Brain Tumor Diagnosis and Treatments Analysis and Forecast
11.1. Market Value Forecast By Country, 2017-2025
11.1.1. China
11.1.2. India
11.1.3. Japan
11.1.4. Rest of Asia Pacific
11.2. Market Value Forecast By Product Type
11.3. Market Value Forecast By Diagnosis Type
11.4. Market Value Forecast By Treatment Type
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Product Type
11.5.3. By Diagnosis Type
11.5.4. By Treatment Type
12. Latin America Brain Tumor Diagnosis and Treatments Analysis and Forecast
12.1. Market Value Forecast By Country, 2017-2025
12.1.1. Brazil
12.1.2. Mexico
12.1.3. Rest of Latin America
12.2. Market Value Forecast By Product Type
12.3. Market Value Forecast By Diagnosis Type
12.4. Market Value Forecast By Treatment Type
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product Type
12.5.3. By Diagnosis Type
12.5.4. By Treatment Type
13. Middle East and Africa Brain Tumor Diagnosis and Treatments Analysis and Forecast
13.1. Market Value Forecast By Country, 2017-2025
13.1.1. South Africa
13.1.2. Saudi Arabia
13.1.3. Rest of Middle East and Africa
13.2. Market Value Forecast By Product Type
13.3. Market Value Forecast By Diagnosis Type
13.4. Market Value Forecast By Treatment Type
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product Type
13.5.3. By Diagnosis Type
13.5.4. By Treatment Type
14. Competition Landscape
14.1. Heat Map Analysis By Company (2016)
14.2. Competition Matrix
14.3. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy )
14.3.1. AstraZeneca
14.3.1.1. Company Details
14.3.1.2. Business Overview
14.3.1.3. Financial Overview
14.3.1.4. Strategic Overview
14.3.1.5. SWOT Analysis
14.3.1.6. Recent Development
14.3.2. Carestream Health
14.3.2.1. Company Details
14.3.2.2. Business Overview
14.3.2.3. Financial Overview
14.3.2.4. Strategic Overview
14.3.2.5. SWOT Analysis
14.3.2.6. Recent Development
14.3.3. GE Healthcare
14.3.3.1. Company Details
14.3.3.2. Business Overview
14.3.3.3. Financial Overview
14.3.3.4. Strategic Overview
14.3.3.5. SWOT Analysis
14.3.3.6. Recent Development
14.3.4. Hitachi Medical Corporation
14.3.4.1. Company Details
14.3.4.2. Business Overview
14.3.4.3. Financial Overview
14.3.4.4. Strategic Overview
14.3.4.5. SWOT Analysis
14.3.4.6. Recent Development
14.3.5. Merck & Co., Inc.
14.3.5.1. Company Details
14.3.5.2. Business Overview
14.3.5.3. Financial Overview
14.3.5.4. Strategic Overview
14.3.5.5. SWOT Analysis
14.3.5.6. Recent Development
14.3.6. Philips Healthcare
14.3.6.1. Company Details
14.3.6.2. Business Overview
14.3.6.3. Financial Overview
14.3.6.4. Strategic Overview
14.3.6.5. SWOT Analysis
14.3.6.6. Recent Development
14.3.7. Pfizer, Inc.
14.3.7.1. Company Details
14.3.7.2. Business Overview
14.3.7.3. Financial Overview
14.3.7.4. Strategic Overview
14.3.7.5. SWOT Analysis
14.3.7.6. Recent Development
14.3.8. Shimadzu Corporation
14.3.8.1. Company Details
14.3.8.2. Business Overview
14.3.8.3. Financial Overview
14.3.8.4. Strategic Overview
14.3.8.5. SWOT Analysis
14.3.8.6. Recent Development
14.3.9. Siemens Healthineers
14.3.9.1. Company Details
14.3.9.2. Business Overview
14.3.9.3. Financial Overview
14.3.9.4. Strategic Overview
14.3.9.5. SWOT Analysis
14.3.9.6. Recent Development
14.3.10. Toshiba Medical System Corporation
14.3.10.1. Company Details
14.3.10.2. Business Overview
14.3.10.3. Financial Overview
14.3.10.4. Strategic Overview
14.3.10.5. SWOT Analysis
14.3.10.6. Recent Development
List of Tables
TABLE 1 Global Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Product Type, 2017–2025
TABLE 2 Global Primary Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Product Type, 2017–2025
TABLE 3 Global Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Diagnosis Type, 2017–2025
TABLE 4 Global Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
TABLE 5 Global Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Region, 2017–2025
TABLE 6 North America Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Country, 2017–2025
TABLE 7 North America Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Product Type, 2017–2025
TABLE 8 North America Primary Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Product Type, 2017–2025
TABLE 9 North America Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Diagnosis Type, 2017–2025
TABLE 10 North America Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Treatment Type, 2017–2025
TABLE 11 Europe Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Country, 2017–2025
TABLE 12 Europe Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Product Type, 2017–2025
TABLE 13 Europe Primary Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Product Type, 2017–2025
TABLE 14 Europe Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Diagnosis Type, 2017–2025
TABLE 15 Europe Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
TABLE 16 Asia Pacific Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Country, 2017–2025
TABLE 17 Asia Pacific Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Product Type, 2017–2025
TABLE 18 Asia Pacific Primary Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Product Type, 2017–2025
TABLE 19 Asia Pacific Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Diagnosis Type, 2017–2025
TABLE 20 Asia Pacific Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
TABLE 21 Latin America Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Country, 2017–2025
TABLE 22 Latin America Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Product Type, 2017–2025
TABLE 23 Latin America Primary Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Product Type, 2017–2025
TABLE 24 Latin America Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Diagnosis Type, 2017–2025
TABLE 25 Latin America Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
TABLE 26 Middle East & Africa Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Country, 2017–2025
TABLE 27 Middle East & Africa Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Product Type, 2017–2025
TABLE 28 Middle East & Africa Primary Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Product Type, 2017–2025
TABLE 29 Middle East & Africa Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Diagnosis Type, 2017–2025
TABLE 30 Middle East & Africa Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
List of Figures
FIG. 1 Global Brain Tumor Diagnosis and Therapeutics Market Size (US$ Mn) and Forecast, 2016–2025
FIG. 2 Brain Tumor Diagnosis and Treatment Market Value share, by Product Type (2016)
FIG. 3 Brain Tumor Diagnosis and Treatment Market Value share, by Diagnosis Type (2016)
FIG. 4 Brain Tumor Diagnosis and Treatment Market Value share, by Treatment Type (2016)
FIG. 5 Brain Tumor Diagnosis and Treatment Market Value share, by Region (2016)
FIG. 6 Global Brain Tumor Diagnosis and Treatment Market Value Share Analysis, by Product Type, 2016 and 2025
FIG. 7 Global Primary Brain Tumor Diagnosis and Treatment Market Value Share Analysis, by Product Type, 2016 and 2025
FIG. 8 Global Primary Brain Tumor Diagnosis and Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
FIG. 9 Global Secondary Brain Tumor Diagnosis and Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
FIG. 10 Global Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Product Type
FIG. 11 Global Brain Tumor Diagnosis and Treatment Market Value Share Analysis, by Diagnosis Type, 2016 and 2025
FIG. 12 Global CT Scan Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2025
FIG. 13 Global MRI Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017-2025
FIG. 14 Global PET-CT Scan Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2025
FIG. 15 Global Molecular Testing Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017-2025
FIG. 16 Global EEG Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2025
FIG. 17 Global Others Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017-2025
FIG. 18 Global Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Diagnosis Type
FIG. 19 Global Brain Tumor Diagnosis and Treatment Market Value Share Analysis, by Treatment Type, 2016 and 2025
FIG. 20 Global Surgery Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2025
FIG. 21 Global Radiation Therapy Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017-2025
FIG. 22 Global Targeted Therapy Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2025
FIG. 23 Global Chemotherapy Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2025
FIG. 24 Global Immunotherapy Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017-2025
FIG. 25 Global Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Treatment Type
FIG. 26 North America Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 27 Europe Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 28 Asia Pacific Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 29 Latin America Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 30 MEA Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 31 Global Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Region
FIG. 32 U.S. Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 33 Canada Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 34 North America Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Country
FIG. 35 North America Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Product Type
FIG. 36 North America Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Diagnosis Type
FIG. 37 North America Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Treatment Type
FIG. 38 Germany Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 39 Spain Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 40 France Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 41 U.K. Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 42 Italy Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 43 Rest of Europe Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 44 Europe Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Country
FIG. 45 Europe Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Product Type
FIG. 46 Europe Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Diagnosis Type
FIG. 47 Europe Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Treatment Type
FIG. 48 China Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 49 India Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 50 Japan Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 51 Rest of APAC Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 52 Asia Pacific Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Country
FIG. 53 Asia Pacific Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Product Type
FIG. 54 Asia Pacific Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Diagnosis Type
FIG. 55 Asia Pacific Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Treatment Type
FIG. 56 Brazil Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 57 Mexico Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 58 Rest of LATAM Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 59 Latin America Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Country
FIG. 60 Latin America Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Product Type
FIG. 61 Latin America Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Diagnosis Type
FIG. 62 Latin America Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Treatment Type
FIG. 63 South Africa Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 64 Saudi Arabia Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 65 Rest of MEA Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 66 Middle East & Africa Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Country
FIG. 67 Middle East & Africa Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Product Type
FIG. 68 Middle East & Africa Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Diagnosis Type
FIG. 69 Middle East & Africa Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Diagnosis Type
FIG. 70 Figure 70: Heat Map Analysis By Company (2016)
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Brain Tumor Diagnosis and Treatments Market
